HOME >> MEDICINE >> NEWS
New drug regimen shows clear benefit for treating advanced colorectal cancer

Initial results from a large, randomized clinical trial for patients with advanced colorectal cancer show that those who received a regimen containing the investigational drug oxaliplatin lived months longer than those who received a standard therapy. Patients on the oxaliplatin regimen, known as FOLFOX4, also had a longer time before their tumors progressed, a better response rate, and fewer severe side effects.

Sponsored by the National Cancer Institute (NCI), the trial has been conducted by a network of researchers led by the North Central Cancer Treatment Group (NCCTG).* Study chair Richard Goldberg, M.D., of the Mayo Clinic Cancer Center, Rochester, Minn., presented the new data today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Fla.

"This trial has given us important new information about the treatment of advanced colorectal cancer," said Richard Kaplan, M.D., chief of NCI's Clinical Investigations Branch, who coordinates colorectal cancer treatment trials sponsored by NCI. "The patient benefit seen with the FOLFOX4 regimen is encouraging; FOLFOX4 is a promising new option in our armamentarium of treatments for colorectal cancer."

The trial, known as N9741, compared three drug regimens: 1) a standard (control) treatment, known as IFL (irinotecan/5-fluorouracil/leucovorin) or the "Saltz regimen," 2) the experimental regimen FOLFOX4 (5-fluorouracil/leucovorin/oxaliplatin) and 3) another experimental regimen combining oxaliplatin and irinotecan.

In a planned interim analysis of the data, the researchers found that outcomes for patients receiving FOLFOX4 were significantly better than for those on the control arm, IFL. Patients on the FOLFOX4 arm lived about four months longer than those on the IFL arm (median 18.6 months vs. 14.1 months). They also had a significantly better time to tumor progression (median 8.8 months vs. 6.9 months) and higher response rates (38 percent vs. 29 perc
'"/>

Contact: NCI Press Office
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute
18-May-2002


Page: 1 2 3

Related medicine news :

1. Study examines three-day antibiotic regimens for treating bladder infection in women
2. Study assessing once daily Abacavir (ABC) in a once daily ART regimen
3. Study compares three weekly regimens of chemotherapy for lung cancer
4. Vitamin E fails to join heart-health regimen
5. Newer lung cancer treatments extend survival longer than traditional regimens
6. Emory University will conduct clinical trial of anthrax vaccine regimen
7. 7-day-on, 7-day-off regimen could reduce cost, toxicities of HIV therapy
8. Drug regimen adherence key in keeping babies virus-free, study suggests
9. HIV patients more likely to accept a drug regimen if they trust in the physician, Yale researchers find
10. Are people with HIV sticking to their medication treatment regimens? New method measures patient adherence
11. Study compares efficacy and adherence to triple nucleoside therapy Ziagen + Combivir with protease inhibitor plus Combivir regimens in therapy-nave

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/14/2019)... ... ... Reset Summer Camp, one of the only summer camp programs specifically designed for ... application portal for summer 2019. In addition, the camp has appointed top parenting ... popularly known as Dr. G – to oversee family engagement. , “We’re excited to ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... Cell & ... Approval, **An FDAnews Webinar**, Thursday, March 28, 2019, 1:30 p.m. - 3:00 p.m. EDT, ... 10 to 20 cell and gene therapy products a year. , That will ...
(Date:3/12/2019)... ... March 12, 2019 , ... ... events, AdventHealth care teams will provide comprehensive, on-site services at the exclusive Midway ... by Advanced Auto Parts. The Infield Care Center will be staffed with emergency ...
(Date:3/12/2019)... BEACH, Calif. (PRWEB) , ... March 12, 2019 ... ... , today announced the availability of HIPAA training for healthcare organizations and their ... to comply with HIPAA regulations and keep patients’ personal and health information private ...
(Date:3/12/2019)... ... 2019 , ... When it comes to selecting a physician ... pain and diseases of joints, muscles, tendons and ligaments, “choose wisely,” says noted ... Indiana Jones. , “Some clinics and health centers have been built on the ...
Breaking Medicine News(10 mins):
(Date:3/16/2019)... ... March 16, 2019 , ... Oral surgeons ... to announce that they are launching the JawFixers Implant Synergy Boot Camp. The first ... series is designed for implant clinicians to better understand the placement of and newest ...
(Date:3/15/2019)... ... , ... Peter Saltonstall , president and chief executive officer at the ... Institute’s 18th annual commencement ceremony on May 18, 2019. , NORD, now in ... than 30 years as a senior executive in both for-profit and not-for-profit healthcare environments. ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... (MBE) LOUi Consulting Group, Inc. (LCGI) its fourth consecutive multi-million-dollar electronic health records ... a $7M, 22-month contract to maintain the computer servers that gather and share ...
Breaking Medicine Technology:
Cached News: